Cloudpharm announces the approval of the funded project “Cloudscreen” in collaboration with the Institute of Chemical Biology of the National Hellenic Research Foundation (NHRF). The objective of the project is the development of a next generation “one-stop-shop”...
Cloudpharm announces the approval of the funded project “OSTEOME” in collaboration with the Musculoskeletal Diseases Research Laboratory “Th. Garofalidis ”of the Medical School of EKPA, the Institute of Chemical Biology of the National Research Foundation (NHRF), the...
In this work, Cloupharm has been involved in the discovery of four compounds through a virtual screening procedure as putative sterol 14α-demethylase (CYP51) Candida albicans inhibitors. The compounds had the ability to inhibit growth of C. albicans cells and one was...
Cloudpharm supports the “Targeted Drug Discovery” workshop, which is the first interactive workshop in Greece focusing on the Drug design and development pipeline aiming to integrate all the related topics from structure-based drug design to preclinical...
In this editorial, we argue for a holistic view of evidence-based practices via the synergy of human and artificial intelligence in drug discovery. This strategy may build a collaborative conceptual framework to enable better-informed and rapid decisions, and the...
